Northside Hospital Central Research Department — Atlanta, Georgia

Northside Hospital Central Research Department is a clinical research site located in Atlanta, Georgia, United States 30342.

Crixeo Clinical Trials Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

Northside Hospital Central Research Department has participated in 7 clinical trials with 3 currently active.

Therapeutic areas: Breast Cancer, Cancer, HER2-positive Breast Cancer.

Sponsors: Bristol-Myers Squibb, Seagen, a wholly owned subsidiary of Pfizer, Gilead Sciences.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Atlanta

Browse all research sites in Georgia · View every site in Atlanta

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northside Hospital Central Research Department?

Northside Hospital Central Research Department has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northside Hospital Central Research Department conducted?

Northside Hospital Central Research Department has 7 clinical trials on record, with 3 currently active. Their work covers Breast Cancer, Cancer, HER2-positive Breast Cancer.

Is Northside Hospital Central Research Department accredited by Crixeo Clinical Trials?

Northside Hospital Central Research Department has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northside Hospital Central Research Department?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.